Public Agenda NewsPaperPublic Agenda NewsPaper
  • General News
  • Politics
  • Business
  • Health
  • Development Agenda
  • World News
  • Features & Opinions
  • Election watch
  • Editorial
Font ResizerAa
Public Agenda NewsPaperPublic Agenda NewsPaper
Font ResizerAa
  • General News
  • Politics
  • Business
  • Health
  • Development Agenda
  • World News
  • Features & Opinions
  • Election watch
  • Editorial
Search
  • General News
  • Politics
  • Business
  • Health
  • Development Agenda
  • World News
  • Features & Opinions
  • Election watch
  • Editorial
Follow US
Breaking NewsHealth

Covid-19: World’s first human trials given green light in UK

Suleman
Last updated: February 17, 2021 1:08 pm
Suleman
Share
3 Min Read
Scientists want to understand more about how the virus affects people
SHARE

Healthy, young volunteers will be infected with coronavirus to test vaccines and treatments in the world’s first Covid-19 “human challenge” study, which will take place in the UK.

The study, which has received ethics approval, will start in the next few weeks and recruit 90 people aged 18-30.

They will be exposed to the virus in a safe and controlled environment while medics monitor their health.

More Read

From Trauma to Recovery: Strenthening Support for Victims of Torture
Drug networks infiltrating schools – NACOC warns
NDC renames National Headquarters after J. J Rawlings
GTMO Condemns Attack on Forestry Commission Checkpoint in Bono East Region
World leaders converge in Accra for high-level reparatory justice conference

The UK has given doses of a Covid vaccine to more than 15 million people.

Human challenge studies have played a vital role in pushing the development of treatments for a number of diseases, including malaria, typhoid, cholera and flu.

  • n

The trials will help scientists work out the smallest amount of coronavirus needed to cause infection, and how the body’s immune system reacts to it.

This will give doctors a better understanding of Covid-19, the disease caused by the virus, which will feed into the development of vaccines and treatments.

‘Unique insights’

The Human Challenge study is being delivered by a partnership between the UK government’s Vaccines Taskforce, Imperial College London, the Royal Free London NHS Foundation Trust and the company hVIVO, which has pioneered viral human challenge models.

Clive Dix, interim chair of the Vaccines Taskforce, said: “We have secured a number of safe and effective vaccines for the UK, but it is essential that we continue to develop new vaccines and treatments for Covid-19.

“We expect these studies to offer unique insights into how the virus works and help us understand which promising vaccines offer the best chance of preventing the infection.”

Initially, the study will use the virus that has been circulating in the UK since the pandemic began in March, which is of low risk to healthy adults, to deliberately infect volunteers.

In time, a small numbers of volunteers are likely to be given an approved vaccine and then exposed to the virus, helping scientists to find out the most effective ones.

Volunteers are being asked to come forward and take part in the study. They will be compensated for their time, the government says.

Chief investigator Dr Chris Chiu, from Imperial College London, said: “We are asking for volunteers aged between 18 and 30 to join this research endeavour and help us to understand how the virus infects people and how it passes so successfully between us.”

Dr Chiu said the eventual aim was to find out which vaccines and treatments work best in beating the disease.

Source:BBC

Share This Article
Facebook Whatsapp Whatsapp Email Copy Link Print

Recent Posts

  • From Trauma to Recovery: Strenthening Support for Victims of Torture
  • Drug networks infiltrating schools – NACOC warns
  • NDC renames National Headquarters after J. J Rawlings
  • GTMO Condemns Attack on Forestry Commission Checkpoint in Bono East Region
  • World leaders converge in Accra for high-level reparatory justice conference
  • Mining, water supply and transport emerge biggest drivers of Producer Price Inflation
  • “Men’s Mental Health: Breaking the Silence, Saving lives
  • NADeF Micro-Credit beneficiaries seek increased funding amid business growth
  • Gbetsile: Six-year-old girl drowns in septic tank while searching for water
  • Recurring Floods Continue to Threaten Lives and Property in Oyibi Community
  • Africa poised to lead global digital finance evolution — MTN CEO
  • Ghana risks outsourcing economic sovereignty under IMF PCI deal — ISODEC
  • Accountability Labs Engage Birim North Assembly on Development Needs
  • How Africa can escape the debt trap
  • US lists travel, visa requirements for World Cup fans
  • Mahama to lead decisive Cabinet meeting over Constitution Review today
  • Ghana’s economy expands by 7.7% in February 2026 – GSS
  • President Mahama urges African leaders to unite in tackling healthcare challenges

You Might Also Like

Breaking NewsBusiness

Mining, water supply and transport emerge biggest drivers of Producer Price Inflation

June 18, 2026
Breaking NewsHealth

“Men’s Mental Health: Breaking the Silence, Saving lives

June 15, 2026
Breaking NewsBusinesstop stories

NADeF Micro-Credit beneficiaries seek increased funding amid business growth

May 31, 2026
Breaking NewsGeneral Newstop stories

Gbetsile: Six-year-old girl drowns in septic tank while searching for water

May 25, 2026

About Us

Public Agenda is fou­nded and owned by Pu­blic Agenda Communic­ations.

Public Agenda was founded as a public interest Me­dia entity. Its Visi­on is to contribute to building a well-i­nformed society where accurate informati­on dissemination is the cornerstone of a democratic, just and equitable society.

Its mission is to inform, guide and bui­ld responsible citiz­enship and accountab­le decision making and strive for excell­ence in the media in­dustry. Public Agenda Communications is managed by a Board of Directors.

  • Contact us
  • Advertise with us
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?